National Bank Of Canada Penumbra Inc Transaction History

National Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$240.69 - $338.77 $1.51 Million - $2.13 Million	-6,288 Reduced 92.66%	498 $120,000
Q2 2023 Jul 26, 2023	BUY	$271.54 - $344.06 $1.84 Million - $2.33 Million	6,786 New	6,786 $2.33 Million
Q2 2022 Jul 28, 2022	SELL	$116.09 - $227.33 $1.87 Million - $3.66 Million	-16,109 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$187.51 - $283.98 $2.96 Million - $4.48 Million	15,790 Added 4949.84%	16,109 $3.58 Million
Q4 2021 Jan 24, 2022	BUY	$238.08 - $288.0 $75,947 - $91,872	319 New	319 $91,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.